Patents Assigned to NANOTICS, LLC
  • Patent number: 11771744
    Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: October 3, 2023
    Assignee: NaNotics, LLC
    Inventor: Louis Hawthorne
  • Patent number: 11065345
    Abstract: The disclosure provides, methods for preparing scavenging particles, as well as methods for attaching capture agents to the particles. The disclosure further provides compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: July 20, 2021
    Assignee: NaNotics, LLC
    Inventors: Louis Hawthorne, John Dodgson
  • Patent number: 10888602
    Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: January 12, 2021
    Assignee: NaNotics, LLC
    Inventor: Louis Hawthorne
  • Patent number: 10653790
    Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of particles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target (or pathogen) from interacting with other molecules or cells.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: May 19, 2020
    Assignee: NaNotics, LLC
    Inventors: John Dodgson, Louis Hawthorne
  • Patent number: 10420817
    Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: September 24, 2019
    Assignee: NaNotics, LLC
    Inventor: Louis Hawthorne
  • Patent number: 9907831
    Abstract: The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: March 6, 2018
    Assignee: NANOTICS, LLC
    Inventor: Louis Hawthorne